Skip to main content

Aims and scope

Cell Regeneration aims to provide a worldwide platform for researches on stem cells and regenerative biology to develop basic science and to foster its clinical translation in medicine. Cell Regeneration welcomes reports on novel discoveries, theories, methods, technologies, and products in the field of stem cells and regenerative research, the journal is interested, but not limited to the following topics:

◎ Embryonic stem cells
◎ Induced pluripotent stem cells
◎ Tissue-specific stem cells
◎ Tissue or organ regeneration
◎ Methodology
◎ Biomaterials and regeneration
◎ Clinical translation or application in medicine

Archival content

Cell Regeneration was transferred back to Springer Nature in 2020. To browse articles published in the journal during 2017 and 2019, please visit this site hosted by the previous publisher. All the other content are available on the current journal website.


Journal News

We are excited to announce that Cell Regeneration has been accepted for inclusion in Emerging Sources Citation Index (ESCI), Biological Abstracts and BIOSIS Previews.

Recent Collections

The Author Talks

View our most recent Author Talks.

Recruiting Vice Editor-in-Chief

Message from the Editor-in-Chief

Cell Regeneration, an open access academic journal, was relaunched by the Chinese Society for Cell Biology in 2019. The journal, founded by the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences in 2012, has published many outstanding papers in the past few years. As an official journal of the Society, Cell Regeneration has undergone major actions such as reorganization of the editorial board and reorientation of journals with new scopes. In 2020, the Society and Springer began co-publishing Cell Regeneration, hoping to better serve the authors and the readers. We aim to position the journal at the forefront of basic and applied research of stem cell biology, regenerative biology and regenerative medicine, including embryonic stem cells, induced pluripotent stem cells, tissue stem cells, tissue and organ regeneration, related methodology, biomaterials, regenerative medical applications and associated research.

The journal publishes original research and review articles and is committed to maintain high quality standard and provide efficient peer-reviews and publishing services. We wish to take this opportunity to sincerely invite you to submit your manuscripts to the journal.  

Ye-Guang Chen
Editor-in-Chief

Annual Journal Metrics

  • 2022 Citation Impact
    0.645 - SNIP (Source Normalized Impact per Paper)
    1.010 - SJR (SCImago Journal Rank)

    2023 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    95 days submission to accept (Median)

    2023 Usage 
    241,999 downloads
    146 Altmetric mentions